🔗 Share this article

A shadow market for unapproved weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Experimental Treatment Gaining Popularity Online

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are encouraged to message these profiles privately for supplier links, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a robust market exists on messaging services, where groups with thousands of members share comparison images, injection guides and claims of rapid British shipping. Sellers promote the drug there before directing customers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Experts Express Worries

Nevertheless, physicians and pharmacists have cautions that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could result in individuals injecting products of uncertain source.

Several experts stated the popularity for retatrutide could be connected to the rising price of approved weight loss products such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be marketed or supplied for human use under the British medical regulations.

Some influencers try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still breach pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or prison.

Service Reaction and Material Elimination

According to TikTok, the service has removed problematic material and prohibited related hashtags and query recommendations. The organization stated it was committed to keeping the service secure and investing in strengthening compliance measures.

Digital Marketplace Operations

Investigations also found communities with up to 9,000 participants selling retatrutide using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly displays groups with numerous of users, populated with images of slimming results, positive testimonials and detailed instructions for preparing or administering at home.

Within minutes of entering one group, a seller posted contact information, where the majority of transactions occur. The vendor provided an guidebook and guaranteed shipping within two days. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None asked about body mass, health issues or previous experience.

Item Details and Costs

Within these groups, posts display dark colored packages with Royal Mail labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with sterile water, or ready-to-use injectors usually sold at 160 pounds for 20mg. When asked how long a pen should be used, sellers give contradictory answers varying between a several days to “depends on your body”.

Service Moderation and Safety Actions

A representative for the messaging service said it regularly moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting substances they can’t verify. Even if the science behind this drug is valid, these digital products may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

A medical professional of an online medical service connected the increase in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, patients are using social media. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.

Her staff has previously seen patients harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a company experimental product not yet authorized … may subject users to potentially significant medical dangers”.